Page last updated: 2024-09-03

n(6)-carboxymethyllysine and Heart Failure

n(6)-carboxymethyllysine has been researched along with Heart Failure in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agostoni, P; Aldini, G; Banfi, C; Brioschi, M; Gianazza, E; Martinez Fernandez, A; Regazzoni, L1
Ballerin, L; Boschetto, P; Campo, I; Casimirri, E; Ceconi, C; Fabbri, LM; Fucili, A; Gorrini, M; Luisetti, M; Papi, A; Potena, A; Stendardo, M; Tinelli, C1
Hartog, JW; Voors, AA; Willemsen, S1
Hartog, JW; Hillege, HL; Jaarsma, T; Roze, JF; Schalkwijk, C; van der Horst, IC; van der Meer, P; van Veldhuisen, DJ; Voors, AA; Willemsen, S1
Cirillo, M; Cotrufo, M; De Santo, LS; De Santo, NG; Frangiosa, A; Heidland, A; Klassen, A; Perna, A; Rossi, F; Schinzel, R; Sebeková, K1
Bakker, SJ; Damman, K; Hartog, JW; Schalkwijk, CG; Scheijen, J; Smilde, TD; Smit, AJ; van Veldhuisen, DJ; Voors, AA1

Other Studies

6 other study(ies) available for n(6)-carboxymethyllysine and Heart Failure

ArticleYear
Pro-oxidant and pro-inflammatory effects of glycated albumin on cardiomyocytes.
    Free radical biology & medicine, 2019, 11-20, Volume: 144

    Topics: Aged; Case-Control Studies; Cell Death; Cell Line; Dyslipidemias; Female; Gene Expression Profiling; Gene Ontology; Glycated Serum Albumin; Glycation End Products, Advanced; Glycosylation; Heart Failure; HSP90 Heat-Shock Proteins; Humans; Hypertension; Interleukin-6; Lysine; Male; Middle Aged; Molecular Sequence Annotation; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Protein Carbonylation; Protein Processing, Post-Translational; Reactive Oxygen Species; Serum Albumin; Serum Albumin, Human; Tumor Necrosis Factor-alpha

2019
Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD.
    European journal of clinical investigation, 2013, Volume: 43, Issue:6

    Topics: Aged; Biomarkers; Case-Control Studies; Chronic Disease; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Heart Failure; Humans; Lysine; Male; Natriuretic Peptide, Brain; Peptide Fragments; Pulmonary Disease, Chronic Obstructive

2013
What is the influence of renal function on the prognostic value of advanced glycation end-products and sRAGE in heart failure?
    Journal of cardiac failure, 2008, Volume: 14, Issue:7

    Topics: Biomarkers; Creatinine; Glomerular Filtration Rate; Glycation End Products, Advanced; Heart Failure; Humans; Kidney; Lysine; Prognosis; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Risk Factors

2008
The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction.
    American heart journal, 2012, Volume: 164, Issue:5

    Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Female; Glycation End Products, Advanced; Heart Failure; Humans; Kaplan-Meier Estimate; Lysine; Male; Mass Spectrometry; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Severity of Illness Index; Stroke Volume

2012
Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation.
    Heart (British Cardiac Society), 2004, Volume: 90, Issue:11

    Topics: Adolescent; Adult; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Glycation End Products, Advanced; Heart Failure; Heart Transplantation; Humans; Kidney Failure, Chronic; Lipid Peroxidation; Lysine; Male; Middle Aged

2004
Clinical and prognostic value of advanced glycation end-products in chronic heart failure.
    European heart journal, 2007, Volume: 28, Issue:23

    Topics: Aged; Biomarkers; Female; Follow-Up Studies; Glycation End Products, Advanced; Heart Failure; Humans; Lysine; Male; Middle Aged; Prognosis; Risk Assessment; Risk Factors; Survival Analysis

2007